Decisive Consulting
Decisive Consulting is a London-based life sciences consultancy providing market access, HEOR, HTA, pricing, and launch strategy services to pharmaceutical and biotechnology companies, now operating as part of the Acumetis platform following the 2026 merger.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Decisive Consulting does
Decisive Consulting is a London-headquartered life sciences consultancy founded in 2020 by Esther Nzenza, specializing in market access strategy, health economics and outcomes research (HEOR), HTA preparation, pricing and reimbursement strategy, and launch planning for pharmaceutical and biotechnology clients. The firm operates through a set of branded service modules — LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR), and VALUATE (pricing/reimbursement) — underpinned by a proprietary "Rebel Thinking" methodology that emphasizes creative problem-solving in challenging reimbursement environments. Decisive has supported more than 45 companies since inception, serving enterprise pharma (including top-10 pharma) and biotech clients across oncology, rare disease, biosimilars, and general medicine.
Decisive monetizes through project-based consulting engagements delivered by senior consultant-led teams directly to enterprise clients, with no publicly disclosed pricing. The firm has productized certain capabilities via PICO Predict, an AI-enabled PICO extraction tool built on GPT-4 that processes over 680,000 clinical trial abstracts with reported 98% completeness and 92.4% accuracy, and JCA-Lab, a coordinated service bundle developed with the Herspiegel group for EU Joint Clinical Assessment preparation.
In June 2025, Herspiegel acquired Decisive, with founder Esther Nzenza transitioning to Senior Partner Global Value and Market Access. In April 2026, Decisive merged with Herspiegel, Adivo Associates, FIECON, and Sixsense Strategy Group to form Acumetis, a 350+ expert, 50+ market global life sciences commercialization platform backed by DFW Capital. Decisive now operates as part of the Acumetis brand, with its original website redirecting to Acumetis.
Decisive Consulting firmographics
Firmographics- Name
- Decisive Consulting
- Legal name
- Decisive Consulting Ltd.
- Website
- https://teamdecisive.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Decisive Consulting is a London-based life sciences consultancy providing market access, HEOR, HTA, pricing, and launch strategy services to pharmaceutical and biotechnology companies, now operating as part of the Acumetis platform following the 2026 merger.
- Ownership category
- akta.pro rank
Decisive Consulting industry classification
Industry- Product category
- Pharmaceutical Market Access Consulting
- NAICS
- Management Consulting Services (54161), Other Management Consulting Services (541618)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Strategy & Corporate Development Consulting (BPAHACAA)
Keywords
Where Decisive Consulting is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Decisive Consulting business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Strategic Consulting Services: Project-based consulting engagements providing market access strategy, health economics, HTA strategy, and commercialization support to pharmaceutical and biotech companies throughout the product lifecycle.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Decisive Consulting product offering
Product offeringCore offering
Decisive Consulting is a specialist life sciences market access and commercialization consultancy that advises pharmaceutical and biotech companies on strategy, evidence, and execution across the product lifecycle. Engagements cover market access, HTA strategy and submission, health economics and outcomes research, pricing and reimbursement, launch planning, and capability building, organized around four named service modules—LIFT, TRANSFORM, EVIDENCE, and VALUATE—and delivered alongside proprietary AI-enabled tools such as PICO Predict and the JCA-Lab service suite for EU Joint Clinical Assessment preparation.
Product overview
Decisive Consulting is a life sciences market access consultancy that operates as part of the Acumetis global network (following a 2025 acquisition by Herspiegel and subsequent 2026 merger into Acumetis). The firm offers a portfolio of interconnected consulting services organized around four core modules—LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR and value demonstration), and VALUATE (pricing and reimbursement)—supported by proprietary AI-enabled tools including PICO Predict (for JCA PICO prediction) and JCA-Lab (for JCA preparation services). The firm's 'Rebel Thinking' methodology underpins all engagements, emphasizing creative problem-solving for breakthrough market access results.
Differentiator
Problem solved
Functional benefit
Products and services
- PICO Predict AI-enabled solution that assists pharmaceutical and medical device companies in preparing for the European Union's Joint Clinical Assessment (JCA) process by predicting PICO (Population, Intervention, Comparator, Outcomes) elements from clinical trial literature to support early PICO scoping.
- JCA-Lab A range of services brought together by the Herspiegel group of companies (including Decisive and FIECON) to help pharmaceutical, biotech, and ATMP developer companies prepare for and implement Joint Clinical Assessments under EU HTA regulation.
- LIFT Strategic advisory service within Decisive's core offering focused on early evidence planning and development strategy for pharmaceutical and biotech clients preparing assets for market access.
- TRANSFORM Market access transformation service within Decisive's core offering focused on strategic planning and execution support for product launches across European and international markets.
- EVIDENCE Health economics and outcomes research (HEOR) service within Decisive's core offering focused on evidence generation and value demonstration for HTA and payer submissions.
- VALUATE Pricing and reimbursement strategy service within Decisive's core offering focused on valuation, pricing corridors, and market access negotiations with payers.
Quantifiable outcome
- Breakthrough access results even in challenging circumstances
- +2 more outcomes
Companies that use Decisive Consulting
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Decisive Consulting technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature2 records
Decisive Consulting partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- HerspiegelcoreHerspiegel acquired Decisive Consulting in June 2025, integrating Decisive's global market access focused 'Rebel Thinking' with Herspiegel's world-class commercialization services. Decisive Founder Esther Nzenza became Senior Partner Global Value and Market Access at Herspiegel.
- uMedminorDecisive Consulting and uMed announced a partnership to drive data-driven market access success in Cardiometabolic and Parkinson's Disease research. The collaboration offers pharmaceutical and biotech companies rapid access to unique, customizable data and expert guidance to bridge HTA evidence gaps.
- Links Life SciencesminorStrategic partnership providing access to industry specialists and expertise in life sciences consulting.
- Prime MoverminorStrategic partnership providing access to industry specialists and consulting expertise.
- WODA AllianceminorStrategic partnership providing access to industry specialists and consulting expertise.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Decisive Consulting competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Decisive Consulting social profiles
Digital presenceDecisive Consulting financial estimates
Financial estimateRevenue estimate
Valuation estimate
Decisive Consulting leadership team
Management profileNumber of profiles
Profiles1 record
Decisive Consulting funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Decisive Consulting M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Decisive Consulting
What does Decisive Consulting do?
Decisive Consulting is a specialist life sciences market access and commercialization consultancy that advises pharmaceutical and biotech companies on strategy, evidence, and execution across the product lifecycle. Engagements cover market access, HTA strategy and submission, health economics and outcomes research, pricing and reimbursement, launch planning, and capability building, organized around four named service modules—LIFT, TRANSFORM, EVIDENCE, and VALUATE—and delivered alongside proprietary AI-enabled tools such as PICO Predict and the JCA-Lab service suite for EU Joint Clinical Assessment preparation.
Is Decisive Consulting a public or private company?
Decisive Consulting is a private company. It is classified as private equity controlled and is currently operating.
When was Decisive Consulting founded?
Decisive Consulting was founded in 2020. It employs 11 to 50 people.
Where is Decisive Consulting based?
Decisive Consulting is headquartered in London, United Kingdom, in the Europe region.
How does Decisive Consulting make money?
One revenue line is on record: strategic Consulting Services.
Does Decisive Consulting have an API?
No public API is recorded for Decisive Consulting.
What industry is Decisive Consulting in?
Decisive Consulting's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting. Its NAICS code is 54161 and its SIC code is 8742.